RxDoctor Payments Data

Shawn Sanicola, DPM

Podiatrist · Pewaukee, WINPI 1457356305

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,056 of the $3,021 with a category attached, or 68.1%. 25 manufacturers reported payments, led by Organogenesis Inc. at 38.6% of the total. Reporting peaked in 2019 at $1,220 and has fallen 63.8% since, to $442 in 2025.

$3,021in general payments, 2019–2025

Across 74 payments — averaging $40.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • Smith+Nephew$314
  • Stryker$277
  • Johnson & Johnson$228
  • Kerecis Limited$189
  • Fusion Orthopedics USA, LLC$160
  • plus $687 from 19 others

What the payments were for

  • Speaking & faculty fees$1344%
  • Travel & lodging$81527%
  • Food & beverage$2,05668%
  • Entertainment$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,021 in reported general payments places this provider in the 70th percentile of 140 podiatrist providers in Wisconsin.

See all podiatrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$107,351
Medicare patients
391
Services billed
1,580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$169
Methylprednisolone19$159
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$62
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$52

Paid to pharmacies, not to this prescriber.

Other podiatrist in Pewaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →